Mealeys

Recent Posts

Humana Can Sue Drug Maker for Reimbursement of Avandia-Related Expenses
Posted on 29 Jun 2012 by Mealeys

PHILADELPHIA - Medicare Advantage provider Humana Medical Plan Inc. is allowed under Medicare law to seek reimbursement from GlaxoSmithKline PLC (GSK) for the costs of treating insurance customers who were injured by GSK's Avandia diabetes drug, a... Read More

Judge Dismisses Kickback Claims, Allows Off-label Marketing Claim To Continue
Posted on 18 Jun 2013 by Mealeys

PHILADELPHIA - A Pennsylvania federal judge on June 13 dismissed kickback claims from a qui tam False Claim Act (FCA) case in which a pharmaceutical company is accused of wrongfully marketing one of its prescription drugs, thereby causing the submission... Read More

Another Orthofix Manager Sentenced For Fraudulent Medical Device Orders
Posted on 25 Jan 2013 by Mealeys

BOSTON - A former territory manager for Orthofix Inc. was sentenced Jan. 23 to three months of home confinement and one year of probation and ordered to pay $13,000 after pleading guilty to one count of health care fraud for falsifying medical device... Read More

Mealey's Emerging Drugs & Devices Bulletin: Glaxo to Pay $3 Billion Stemming from Drug Marketing
Posted on 2 Jul 2012 by Mealeys

BOSTON -GlaxoSmithKline LLC (GSK) agreed today to plead guilty and to pay $3 billion to resolve broad-ranging criminal and civil allegations in Massachusetts federal court regarding the promotion of several prescription drugs, failure to report safety... Read More

Supreme Court Denies Certiorari; Provider Can Sue For Avandia-Related Expenses
Posted on 15 Apr 2013 by Mealeys

WASHINGTON, D.C. - The U.S. Supreme Court on April 15 denied a petition for writ of certiorari filed by GlaxoSmithKine PLC (GSK), leaving stand a decision allowing a Medicare Advantage provider to seek reimbursement from GSK under Medicare law for the... Read More

Government Seeks Stay Of Plan B Contraceptive Order Pending 2nd Circuit Appeal
Posted on 2 May 2013 by Mealeys

BROOKLYN, N.Y. - The federal government on May 1 asked a judge to stay, pending appeal, his order that the Food and Drug Administration make all Plan B emergency contraceptive products available without age or point-of-sale restrictions, saying the court... Read More

Wisconsin Appeals Court Affirms $22M Drug-Pricing Judgment Against Pharmacia
Posted on 7 Feb 2013 by Mealeys

MADISON, Wis. - A Wisconsin appeals court panel on Feb. 6 upheld a $22 million judgment against Pharmacia Corp. for reporting inflated average wholesale prices (AWPs) that resulted in the state Medicaid program overpaying for prescription drugs (State... Read More

Glaxo to Pay $3 Billion Stemming from Drug Marketing
Posted on 2 Jul 2012 by Mealeys

BOSTON -GlaxoSmithKline LLC (GSK) agreed today to plead guilty and to pay $3 billion to resolve broad-ranging criminal and civil allegations in Massachusetts federal court regarding the promotion of several prescription drugs, failure to report safety... Read More

Podiatrist Admits Lying To Grand Jury Investigating Orthofix Health Care Fraud
Posted on 16 Jan 2014 by Mealeys

BOSTON - A Virginia podiatrist on Jan. 15 pleaded guilty to lying to a federal grand jury during an investigation into health care fraud and kickbacks related to bone growth stimulators sold by Orthofix Holdings Inc. (United States of America v. Ilene... Read More

Ky. Appeals Court Vacates $130M Drug-Pricing Verdicts, Says State Was 'Complicit'
Posted on 15 Oct 2012 by Mealeys

FRANKFORT, Ky. - A Kentucky appeals court panel on Oct. 12 vacated verdicts totaling more than $130.7 million against two drug makers for publishing inflated average wholesale prices (AWPs), saying the Kentucky Medicaid program was well aware of the practice... Read More

Citing Politics, Judge Will Let 2nd Circuit Stay His Plan B Access Order
Posted on 13 May 2013 by Mealeys

BROOKLYN, N.Y. - Saying that the U.S. secretary of Health and Human Services is playing politics and that the Food and Drug Administration inked a "sweetheart" deal with Teva Women's Health, a New York federal judge on May 10 granted only... Read More

Ex-Orthofix Manager Sentenced To 5 Months Of House Arrest For Health Care Fraud
Posted on 10 Jan 2013 by Mealeys

BOSTON - A former manager for medical device maker Orthofix Inc. was sentenced Jan. 9 to five months of home confinement and ordered pay and forfeit $44,000 for defrauding Medicare by falsifying medical records (United States of America v. Derrick R.D... Read More

Florida Appeals Panel Revives Couple's Claims Against Health Care Company
Posted on 19 Jul 2013 by Mealeys

MIAMI - The Third District Florida Court of Appeal on July 17 reversed a trial court decision dismissing claims against a health care provider, ruling that the plaintiffs' claims were not for medical malpractice (Angel Acosta, et al. v. HealthSpring... Read More

Mealey's Emerging Drugs & Devices Bulletin: Humana Can Sue Drug Maker for Avandia Related Expenses
Posted on 29 Jun 2012 by Mealeys

PHILADELPHIA - Medicare Advantage provider Humana Medical Plan Inc. is allowed under Medicare law to seek reimbursement from GlaxoSmithKline PLC (GSK) for the costs of treating insurance customers who were injured by GSK's Avandia diabetes drug, a... Read More

3rd Circuit: Humana Can Sue GSK For Reimbursement For Avandia-Related Expenses
Posted on 29 Jun 2012 by Mealeys

PHILADELPHIA - Medicare Advantage provider Humana Medical Plan Inc. is allowed under Medicare law to seek reimbursement from GlaxoSmithKline PLC (GSK) for the costs of treating insurance customers who were injured by GSK's Avandia diabetes drug, a... Read More